ARCHIVES

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

In Brief: Flood At Ohio’s Arthur James Cancer Hospital Sets Back Opening; Biometry Article Honored

January 19, 1990

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993